Security key
867781502
Sunshine Biopharma Inc. - *W EXP 99/99/999 (SBFMW)
CUSIP: 867781502
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / *W EXP 99/99/999
- Total 13F shares
- 69,844
- Total 13F value
- $27,000
- Share change
- -2,559
- SEC-reported price per share
- $0.39
- Number of holders
- 3
- Value change
- -$927
- Number of sells
- 2
Report period
Q3 2022
Institutions
3
Top holders
3
SBFMW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Sunshine Biopharma Inc. SEC filings
Sunshine Biopharma Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 867781502
Recent filing periods:
Ownership snapshot
Top reported holders of SBFMW - Sunshine Biopharma Inc. - *W EXP 99/99/999 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BRIDGEWAY CAPITAL MANAGEM...
Disclosed value leader
BRIDGEWAY CAPITAL MANAGEM...
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F
3/4/5
Highest disclosed value: $614,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BRIDGEWAY CAPITAL MANAGEMENT, LLC has the largest disclosed position value at $614K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BRIDGEWAY CAPITAL MANAGEMENT, LLC's linked filing trail.
Disclosed position value
Top 5
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$614K
Rabi Kiderchah
$248.1K
James Daniel Kish
$221.1K
Virtu Financial LLC
$52K
BANK OF MONTREAL /CAN/
$40K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$614,000
568,400 shares
|
— | 30 Jun 2022 |
| Rabi Kiderchah |
3/4/5
Director
|
—
denominator unverified
|
$248,138
325,000 shares
|
— | 31 Oct 2021 |
| James Daniel Kish |
3/4/5
Director
|
—
denominator unverified
|
$221,110
289,600 shares
|
— | 31 Oct 2021 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$52,000
47,861 shares
|
— | 30 Jun 2022 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
—
denominator unverified
|
$40,000
31,000 shares
|
— | 30 Jun 2022 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
denominator unverified
|
$38,000
46,857 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
69,844
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q3 2022 holders
3
Holder diff
2
| Investor | Q1 2026 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend